Sicuremi Healthcare Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 4.98 M
as on 08-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 39.26%
(FY 2020)
- Profit -122.66%
(FY 2020)
- Ebitda -132.00%
(FY 2020)
- Net Worth 146.19%
(FY 2020)
- Total Assets 143.77%
(FY 2020)
About Sicuremi Healthcare Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.98 M, as per Ministry of Corporate Affairs (MCA) records.
Yogendra Gupta, Tarun Gupta, and Veena Gupta serve as directors at the Company.
- CIN/LLPIN
U74999UP2018PTC103567
- Company No.
103567
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Sicuremi Healthcare Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogendra Gupta  | Additional Director | 01-Mar-2024 | Current |
| Tarun Gupta | Director | 24-Apr-2018 | Current |
| Veena Gupta | Additional Director | 24-Nov-2023 | Current |
Financial Performance and Corporate Structure Insights of Sicuremi Healthcare Technologies.
Sicuremi Healthcare Technologies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 39.26% increase. The company also saw a substantial fall in profitability, with a 122.66% decrease in profit. The company's net worth Soared by an impressive increase of 146.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sicuremi Healthcare Technologies?
In 2020, Sicuremi Healthcare Technologies had a promoter holding of 91.60% and a public holding of 8.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Foundation For Disease Elimination And Control Of IndiaActive 8 years 3 monthsYogendra Gupta is a mutual person
Bharat Immunologicals And Biologicals Corporation LimitedActive 35 years 9 monthsYogendra Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sicuremi Healthcare Technologies?
Unlock and access historical data on people associated with Sicuremi Healthcare Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sicuremi Healthcare Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sicuremi Healthcare Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
